1-4 of 4
Arthur Shen
Close
Sort by
Journal Articles

Differential gene expression in central nervous system lymphoma

James L. Rubenstein, Arthur Shen, Tracy T. Batchelor, Cigall Kadoch, Patrick Treseler, Marc A. Shuman
Journal: Blood
Blood (2009) 113 (1): 266–267.
https://doi.org/10.1182/blood-2008-04-152835
Published: 2009
Journal Articles

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Samar Issa, MD, Arthur Shen, B.S., Jon Karch, B.S., Cigall Kadoch, B.S., Marc Shuman, M.D., Lloyd Damon, M.D., James Rubenstein, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1364.
https://doi.org/10.1182/blood.V110.11.1364.1364
Published: 2007
Journal Articles

Gene expression and angiotropism in primary CNS lymphoma

Clinical Trials & Observations
James L. Rubenstein, Jane Fridlyand, Arthur Shen, Ken Aldape, David Ginzinger, Tracy Batchelor, Patrick Treseler, Mitchel Berger, Michael McDermott, Michael Prados, Jon Karch, Craig Okada, William Hyun, Seema Parikh, Chris Haqq, Marc Shuman
Journal: Blood
Blood (2006) 107 (9): 3716–3723.
https://doi.org/10.1182/blood-2005-03-0897
Published: 2006
Includes: Supplemental data
Journal Articles

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Clinical Trials & Observations Brief Report
James L. Rubenstein, Dan Combs, Jay Rosenberg, Arthur Levy, Michael McDermott, Lloyd Damon, Robert Ignoffo, Kenneth Aldape, Arthur Shen, Dana Lee, Antonio Grillo-Lopez, Marc A. Shuman
Journal: Blood
Blood (2003) 101 (2): 466–468.
https://doi.org/10.1182/blood-2002-06-1636
Published: 2003